A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gatifloxacin D4 | CAS 1190043-25-4 - Request Quote

Picture of Gatifloxacin D4

Gatifloxacin D4

SZ CAT No:SZ-G004D01
CAS No
1190043-25-4
Mol.F.
C19H18D4FN3O4
Mol.Wt.
379.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Gatifloxacin D4 is chemically 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl-2,2,5,5-d4)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. Gatifloxacin D4 is supplied with detailed characterization data compliant with regulatory guideline. Gatifloxacin D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gatifloxacin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1190043-25-4

Purchase 1190043-25-4

Order 1190043-25-4

Enquire 1190043-25-4

price of 1190043-25-4

1190043-25-4 Supplier

1190043-25-4 Manufacturer

1190043-25-4 Exporter

buy high quality Gatifloxacin D4

Purchase Gatifloxacin D4

Gatifloxacin D4 suppliers

Gatifloxacin D4 manufacturers

Gatifloxacin D4 price

Order Gatifloxacin D4

Enquire Gatifloxacin D4

Gatifloxacin D4 cost

Gatifloxacin D4 Supplier

Gatifloxacin D4 Distributor

Gatifloxacin D4 for Method Validation

Gatifloxacin Reference Standard

Gatifloxacin D4 for ANDA Filing

Gatifloxacin D4 for Forced Degradation Studies

Gatifloxacin D4 Identification Standards

Gatifloxacin D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,